SlideShare a Scribd company logo
1 of 33
Oesophageal
Perforation
HOSPITAL CLINICAL PHARMACY PRESENTATION
Parenteral Nutrition
Group Member:
1.Saw Phin Khye A136315
2.Erma Zufira binti Zuknaini A136657
Preceptor:
Assoc. Prof Fuad Ahmad bin ShamsuddinAssoc. Prof Fuad Ahmad bin Shamsuddin
Patient’s Background
• Ward/Bed: Surgery 2 Bed 7
• Name: LPL
• Gender: Female
• Race: Chinese
• Age: 86 years old
• Weight: 50kg
• Height: 180cm
• BMI: 15.4kg/m2
• BSA: 1.58m2
• DOA: 18th
October 2014
*Date of starting peripheral parenteral nutrition (Kabiven®):
20th
October 2014
• Diagnosis/Problems:
Sepsis 2° to HAP
Emphysema
AKI 2° to dehydration
• Past Medical History:
Esophageal perforation 2° post ERCP
Ascending cholangitis with acute pancreatitis
2° to periampullary tumour
DM Type II
HPT
Medications Upon Admission
(18th
Oct 2014)
Medications Indications
IV Ceftriaxone 2g Serious infection- septicemia and
pneumonia.
IV Hydrocortisone 100mg Septic shock
IV Calcium Chloride 1g Impaired absorption of Ca2+
IV Adrenaline 0.08mg Cardiopulmonary resuscitation
Current Medications
Medications Indications Date
IV Noradrenaline 0.2%
4mg/4ml inj.
Acute hypotension 19th
Oct 2014
Esomeprazole 40mg inj. Gastro-esophageal reflux 19th
until 28th
Oct 2014
Acetylcystein 600mg
effervescent tab.
Paracetamol poisoning 19th
until 22nd
Oct 2014
Piperacillin 4g +
Tazobactam 500mg inj.
(Tazocin)
Septicemia 19th
until 28th
Oct 2014
Potassium chloride 10% inj.
10ml
Hypokalemia 22nd
and 23rd
Oct 2014
Magnesium sulphate 50%
inj. 5ml
Arrhythmias due to
hypokalemia
23rd
Oct 2014
Human albumin 25% inj.
50ml
Hypoalbuminaemia 25th
until 28th
Oct 2014
Cont..
Medications Indications Date
Enoxaparin 60mg inj. 0.6ml Prophylaxis of venous
thromboembolism
27th
and 28th
Oct 2014
Metronidazole
500mg/100ml inj.
Antibiotic
(for anaerobic bacteria)
26th
until 28th
Oct 2014
Imipenem 500mg,
Cilastatin 500mg inj.
Antibiotic 28th
Oct 2014
Indication for TPN
1. Patient have oesophageal perforation
2. Patient was initially unconscious, weak
and bed ridden
Objective of TPN
To provide energy, hydrate patient(resolve
KI) and improve nutrition status
Calculation of PN Regimen
1.Energy Requirement
BMI = 50kg/ (1.8m)2
= 15.43kg/m2
(Underweight)
Harris Benedict Formula
Women:
BEE= 665 + 9.6 x weight (kg) + 1.8 x height(cm) – 4.7 x age(years)
= 665+ 9.6 x 50 kg + 1.8 x 180 cm – 4.7 x 86 years
= 1064.8 kcal/day
Other factors to consider…
1. Confined to Bed - activity factor 1.2
2. Septic Shock - activity factor 1.6
So:
1064.8 kcal x 1.2 x 1.6 = 2044.42kcal2044.42kcal
2. Fluid Requirement
= 100 mL/kg for first 10kg body weight
+ 50 mL/kg for next 10kg body weight
+ 25mL/kg for each kg >20
= 100 mL/kg x 10kg + 50 mL/kg x 10kg +
25 mL/kg x 30kg
= 2250mL2250mL
3. Protein Requirement
Adult:
2 g/kg/day x 50 kg
= 100 g/day100 g/day
1g nitrogen = 6.25 g protein
So, 100g protein contain 16 g nitrogen.
Going back to the kcal..
1 g protein = 4 kcal
100 g protein will contain 400 kcal.
NPC = Total calorie – Protein calorie
= 2044.42kcal – 400kcal
= 1644.42 kcal
NPC:N ratio = Total NPC (kcal) / N (g)
• =1644.42kcal/ 16 g
• = 102 : 1 (Match NPC : N for Stressed Pt)
Condition NPC : N
Maintenance 150 : 1
Stress 90-120 : 1
Infant 200 : 1
NPC : N Ratio
NPC: 43% glucose and 57% lipid
Glucose: 1644.42 kcal x 43%
== 707 kcal707 kcal
Lipid: 1644.42 kcal x 57%
= 937.32 kcal= 937.32 kcal
4. Lipid Requirement
Calories required = 937.32 kcal
Total lipid = 937.32 kcal / 9 kcal/g
= 104.14 g
5. Carbohydrate Requirement5. Carbohydrate Requirement
Calories required = 707 kcal
Total carbohydrate = 707 kcal / 4 kcal/g
= 176.75g
Calculated Requirement
Daily
Requirement
Volume of The
Preparation
Content in the Calculated
Volume
Final
Volume
Protein 100g 100g contains 16g N
16g/13.5g x1000mL =
1185.19 mL ≈ 1185mL
VaminTM14 contains:
Na+ = 0.1 x 1185= 118.5mmol
K+ = 0.05 x 1185= 59.25mmol
Ca+ = 0.005 x 1185= 5.925mmol
Mg+= 0.008 x 1185= 9.48mmol
Cl-
= 0.1x 1185 = 118.5mmol
SO42-
= 0.008 x 1185 =9.48mmol
N=13.5gm/1000mL
1185mL
Lipid 104g 20%= 30g / 100mL
104/30 x 100 =
346.67mL≈ 347mL
Intralipid 20% 347mL
Dextrose 177g 50% = 50g / 100mL
177/50 x 100 = 354mL
Dextrose 50% 354 mL
Calculated Requirement (Cont.)
Daily
Requirement
Volume of the
Preparation
Content in the Calculated
Volume
Final
Volume
Trace Element
(Additrace)
10mL 10mL
Phosphate:
50mmol
(Use K2HPO4Inj )
50 x1 =50mL K2HPO4 Inj contains:
K+
= 2.0 mmol/ml
Phosphate = 1 mmol/l
50 mL
Sodium :
100mmol
From Vamin:
118mmol
0mL
Mg2+
: 10 mmol From Vamin:
9.48mmol
0mL
Calcium : 10 mmol
(Use CaGlu 10%
Inj)
From Vamin:
5.925mmol
4mmol / 0.22mmol x
1mL = 18mL
CaGlu 10% Inj contains:
Ca2+
= 0.22 mmol/ml
18mL
Calculated Requirement (Cont.)
Daily
Requirement
Volume of the
Preparation
Content in the Calculated
Volume
Final
Volume
Potassium: 100
mmol
From K2HPO4 Inj:
2.0 mmol/mL x 50mL
= 100mmol
0mL
Water soluble
vitamin :
(Use Solivito)
10mL
Lipid soluble
vitamin
(Use Vitlipid Adult)
10mL
Fluid
(Water for
Injection)
2250mL – 1984mL =
266mL
266mL
TOTAL VOLUME 2250mL
TPN REGIMEN PROVIDED
Date Regimen Contents
20-10-2014 - 28-10-2014 Kabiven Peripheral Amino Acid 34g
Nitrogen 5.4 g
Glucose 97g
Lipid 51g
Total Energy 1000 kcal
NPC 900kcal
Sodium 32 mmol
Chloride 47 mmol
Calcium 2 mmol
Potassium 24 mmol
Magnesium 4 mmol
Phosphate 11 mmol
Total Volume 1440mL
22-10-2014 & 23-10-
2014
Potassium chloride
10% inj. 10ml
150mg KCl/mL:
Potassium 37mmol
Chloride 42mmol
Overall Comparison and
Comments
TPN Content TPN Prescribed TPN Calculated
Protein 34g 100g
Lipid 51g 104g
Carbohydrate 97g 177g
Total Energy 1900kcal 2044kcal
Sodium 32mmol 90mmol
Chloride 47mmol 80mmol
Calcium 2mmol 10mmol
Potassium 24mmol 100mmol
Magnesium 4mmol 10mmol
Phosphate 11mmol 50mmol
Total Fluid
Volume
1440mL 2250
1. Renal Profile
Increase of urea level ---
indication of high protein
catabolism.
Decreasing level of creatinine
towards normal range
indicated that AKI is treated
properly.
2. Liver Profile
Low level of total protein and albumin is an indicator for
malnutrition. Low level of protein may be due to high
protein catabolism.
Elevated levels of ALP and ALT are because of patient’s
bile duct disease and usage of TPN.
3. Electrolytes Level
Potassium chloride is given to patient on 22nd
and
23rd
Oct in order to ensure she is not having
hypokalemia.
4. Platelet Count
Reduced platelets count indicated the
septicemia.
5. Culture & Sensitivity Test
• 19th
Oct 2014
TEST: Blood Culture Anaerobic (Gram
Negative)
RESULT: + Bacteriodes sp.
6. I/O Chart
• + balance shown that patient is having
fluid retention since DOA, 19th
Oct.
This is due to her AKI problem.
Edema should be noted.
Monitoring Efficacy and
Progress
• Vital signs
 BP, body temperature should be monitored closely as the
patient has septic shock.
• I/O Chart
 To prevent fluid retention or dehydration in patient.
• Anthropometry
 Patient’s body weight and fluid balance monitored.
 Negative fluid balance show success TPN.
• Serum/urine glucose level
 Patient had a history of DM Type II.
 Need to ensure patient can tolerate the glucose content in TPN.
 Blood glucose level should be monitored.
• Renal + electrolytes status
 Indicates appropriate provision or other complicating clinical activity.
 AKI.
• Proteins
 Albumin level is quite low. The patient is malnourished.
 Liver enzymes; ALT and ALP are elevated because of liver duct
problem and usage of TPN.
Monitoring Safety
• Metabolic/ Nutritional complication
 Monitored level of blood glucose level.
 Monitor level of potassium and phosphate to avoid
refeeding syndrome.
• Technical/Mechanical complication
 Check for infection from catheter.
 Monitor vital signs.
Conclusion
The current TPN regimen is not sufficient to fulfill
patient’s daily nutrition requirement.
However, intervention to increase the doses
should be taken only after serious monitoring
and consideration on patient’s current kidney
and liver functions
I/O chart should continue to be monitored
closely.
References
1. Calvin L. Long, Neal Schaffel, John W. Geiger, William R. Schiller and William S.
Blakemore. 1979. Metabolic Response to Injury and Illness: Estimation of Energy
and Protein Needs from Indirect Calorimetry and Nitrogen Balance. Journal of
Parenteral and Enteral Nutrition 3: 452-456.
2. DR Garrel, N Jobin, LHM De Jonge .1996. Should We Still Use the Harris and
Benedict Equations? Nutrition in Clinical Practice Journal 11: 99-103
3. Koneru Veera Raghava Chowdary and Pothula Narasimha Reddy. 2010. Parenteral
nutrition: Revisited. Indian Journal of Anaesthesia 54(2): 95-103
4. Gail A. Cresci. 2005. Nutrition Support for the Critically Ill Patient: A Guide to
Practice. CRC/Taylor & Francis Group.
5. http://www.cancer.org/healthy/toolsandcalculators/calculators/app/body-mass-calculator
6. Assoc. Prof Fuad Ahmad bin Shamsuddin’s lecture notes on Parenteral Nutrition
Support
THANK YOU
Terima Kasih

More Related Content

What's hot

Presentasi Luka Bakar Minggu ke 2 PKL
Presentasi Luka Bakar Minggu ke 2 PKL Presentasi Luka Bakar Minggu ke 2 PKL
Presentasi Luka Bakar Minggu ke 2 PKL
Arif Triyono
 
FSHN 450 liver disease case study
FSHN 450 liver disease case studyFSHN 450 liver disease case study
FSHN 450 liver disease case study
Anya Guy
 
MedReg+1 Matthews Gastro
MedReg+1 Matthews GastroMedReg+1 Matthews Gastro
MedReg+1 Matthews Gastro
MedReg+1
 
Introduction to clinical nutrition
Introduction to clinical nutritionIntroduction to clinical nutrition
Introduction to clinical nutrition
Dr Iyan Darmawan
 

What's hot (20)

Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
CKD case studyyyy
CKD case studyyyyCKD case studyyyy
CKD case studyyyy
 
Presentasi Kanker Payudara Minggu Ke 1
Presentasi Kanker Payudara Minggu Ke 1Presentasi Kanker Payudara Minggu Ke 1
Presentasi Kanker Payudara Minggu Ke 1
 
Nutrition in critically ill patients
Nutrition in critically ill patientsNutrition in critically ill patients
Nutrition in critically ill patients
 
Nutrition in critically ill
Nutrition in critically illNutrition in critically ill
Nutrition in critically ill
 
Obesity: nutrients modulators of neuropeptides and neurotransmmitters
Obesity: nutrients modulators of neuropeptides and neurotransmmitters Obesity: nutrients modulators of neuropeptides and neurotransmmitters
Obesity: nutrients modulators of neuropeptides and neurotransmmitters
 
Daily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically illDaily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically ill
 
Presentasi Luka Bakar Minggu ke 2 PKL
Presentasi Luka Bakar Minggu ke 2 PKL Presentasi Luka Bakar Minggu ke 2 PKL
Presentasi Luka Bakar Minggu ke 2 PKL
 
nutritional need of critical ill child
nutritional need of critical ill childnutritional need of critical ill child
nutritional need of critical ill child
 
FSHN 450 liver disease case study
FSHN 450 liver disease case studyFSHN 450 liver disease case study
FSHN 450 liver disease case study
 
Ketosis 2018 كما لم تعرفها من قبل
Ketosis 2018 كما لم تعرفها من قبلKetosis 2018 كما لم تعرفها من قبل
Ketosis 2018 كما لم تعرفها من قبل
 
Immunonutrition
ImmunonutritionImmunonutrition
Immunonutrition
 
MedReg+1 Matthews Gastro
MedReg+1 Matthews GastroMedReg+1 Matthews Gastro
MedReg+1 Matthews Gastro
 
Introduction to clinical nutrition
Introduction to clinical nutritionIntroduction to clinical nutrition
Introduction to clinical nutrition
 
nutrition in ICU part 2. (Total parenteral nutrition)
nutrition in ICU part 2.   (Total parenteral nutrition)nutrition in ICU part 2.   (Total parenteral nutrition)
nutrition in ICU part 2. (Total parenteral nutrition)
 
Tpn
Tpn Tpn
Tpn
 
Diet and tissue healing
Diet and tissue healingDiet and tissue healing
Diet and tissue healing
 
Supplementary Nutritional Support - SNS / TPN
Supplementary Nutritional Support - SNS / TPNSupplementary Nutritional Support - SNS / TPN
Supplementary Nutritional Support - SNS / TPN
 
total parental nutrition in neonate guidline
total parental nutrition in neonate guidlinetotal parental nutrition in neonate guidline
total parental nutrition in neonate guidline
 
 

Viewers also liked (11)

The rudiments of TPN
The rudiments of TPNThe rudiments of TPN
The rudiments of TPN
 
Total Parenteral Nutrition
Total Parenteral Nutrition Total Parenteral Nutrition
Total Parenteral Nutrition
 
Administering TPN
Administering TPNAdministering TPN
Administering TPN
 
Total Parenteral Nutrition: An Intro
Total Parenteral Nutrition: An IntroTotal Parenteral Nutrition: An Intro
Total Parenteral Nutrition: An Intro
 
Tpn by dr. aakif
Tpn by dr. aakifTpn by dr. aakif
Tpn by dr. aakif
 
Total enteral nutrition and total parenteral nutrition in critically ill pat...
Total enteral nutrition  and total parenteral nutrition in critically ill pat...Total enteral nutrition  and total parenteral nutrition in critically ill pat...
Total enteral nutrition and total parenteral nutrition in critically ill pat...
 
Basic Pharmacy Calculations and Pharmacokinetes
Basic Pharmacy Calculations and PharmacokinetesBasic Pharmacy Calculations and Pharmacokinetes
Basic Pharmacy Calculations and Pharmacokinetes
 
Nutrition in icu
Nutrition in icuNutrition in icu
Nutrition in icu
 
Nutritional Guidelines for ICU Patients
Nutritional Guidelines for ICU PatientsNutritional Guidelines for ICU Patients
Nutritional Guidelines for ICU Patients
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Total parenteral nutrition
Total parenteral nutrition Total parenteral nutrition
Total parenteral nutrition
 

Similar to Tpn 7e

Anorexia Nervosa Case Study
Anorexia Nervosa Case StudyAnorexia Nervosa Case Study
Anorexia Nervosa Case Study
Roanna Martin
 
Hypocalcemia.pptx
Hypocalcemia.pptxHypocalcemia.pptx
Hypocalcemia.pptx
Pedsnahan
 
FSHN450HemodialysisRenalCalcCaseStudy
FSHN450HemodialysisRenalCalcCaseStudyFSHN450HemodialysisRenalCalcCaseStudy
FSHN450HemodialysisRenalCalcCaseStudy
Anna King
 
CASE STUDY 1 (Q2)
 CASE STUDY 1 (Q2) CASE STUDY 1 (Q2)
CASE STUDY 1 (Q2)
Wan Hazirah
 
Liver disease case study
Liver disease case studyLiver disease case study
Liver disease case study
Marissa Uhlhorn
 
2013 iqbal jan9_tpn origin and calculations
2013 iqbal jan9_tpn origin and calculations2013 iqbal jan9_tpn origin and calculations
2013 iqbal jan9_tpn origin and calculations
Shiza Riaz
 
liver disease case study
liver disease case studyliver disease case study
liver disease case study
Rachel Mostek
 
FSHN 450 renal case study
FSHN 450 renal case studyFSHN 450 renal case study
FSHN 450 renal case study
Anya Guy
 
CDK case study pdf nov 13
CDK case study pdf nov 13CDK case study pdf nov 13
CDK case study pdf nov 13
Carolina chaves
 

Similar to Tpn 7e (20)

How I assess nutritional requirements and prescribe TPN
How I assess nutritional requirements and prescribe TPNHow I assess nutritional requirements and prescribe TPN
How I assess nutritional requirements and prescribe TPN
 
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptxTOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
TOTAL PARETERAL NUTRITION and Enteral Nutrition.pptx
 
CKD Case Study
CKD Case StudyCKD Case Study
CKD Case Study
 
Anorexia Nervosa Case Study
Anorexia Nervosa Case StudyAnorexia Nervosa Case Study
Anorexia Nervosa Case Study
 
Hypocalcemia.pptx
Hypocalcemia.pptxHypocalcemia.pptx
Hypocalcemia.pptx
 
FSHN450HemodialysisRenalCalcCaseStudy
FSHN450HemodialysisRenalCalcCaseStudyFSHN450HemodialysisRenalCalcCaseStudy
FSHN450HemodialysisRenalCalcCaseStudy
 
Renal Case Study
Renal Case StudyRenal Case Study
Renal Case Study
 
CASE STUDY 1 (Q2)
 CASE STUDY 1 (Q2) CASE STUDY 1 (Q2)
CASE STUDY 1 (Q2)
 
Vitamin D intoxication
Vitamin D intoxicationVitamin D intoxication
Vitamin D intoxication
 
Critically ill patient on ventilation with transaminitis after nephrectomy
Critically ill patient on ventilation with transaminitis after nephrectomyCritically ill patient on ventilation with transaminitis after nephrectomy
Critically ill patient on ventilation with transaminitis after nephrectomy
 
Nutritional-Support-for peri Operative patients & TPN
Nutritional-Support-for peri Operative patients & TPNNutritional-Support-for peri Operative patients & TPN
Nutritional-Support-for peri Operative patients & TPN
 
Liver disease case study
Liver disease case studyLiver disease case study
Liver disease case study
 
2013 iqbal jan9_tpn origin and calculations
2013 iqbal jan9_tpn origin and calculations2013 iqbal jan9_tpn origin and calculations
2013 iqbal jan9_tpn origin and calculations
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
liver disease case study
liver disease case studyliver disease case study
liver disease case study
 
FSHN 450 renal case study
FSHN 450 renal case studyFSHN 450 renal case study
FSHN 450 renal case study
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
RPGN.pptx
RPGN.pptxRPGN.pptx
RPGN.pptx
 
CDK case study pdf nov 13
CDK case study pdf nov 13CDK case study pdf nov 13
CDK case study pdf nov 13
 
Laporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxLaporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptx
 

Tpn 7e

  • 1. Oesophageal Perforation HOSPITAL CLINICAL PHARMACY PRESENTATION Parenteral Nutrition Group Member: 1.Saw Phin Khye A136315 2.Erma Zufira binti Zuknaini A136657 Preceptor: Assoc. Prof Fuad Ahmad bin ShamsuddinAssoc. Prof Fuad Ahmad bin Shamsuddin
  • 2. Patient’s Background • Ward/Bed: Surgery 2 Bed 7 • Name: LPL • Gender: Female • Race: Chinese • Age: 86 years old • Weight: 50kg • Height: 180cm • BMI: 15.4kg/m2 • BSA: 1.58m2 • DOA: 18th October 2014 *Date of starting peripheral parenteral nutrition (Kabiven®): 20th October 2014
  • 3. • Diagnosis/Problems: Sepsis 2° to HAP Emphysema AKI 2° to dehydration • Past Medical History: Esophageal perforation 2° post ERCP Ascending cholangitis with acute pancreatitis 2° to periampullary tumour DM Type II HPT
  • 4. Medications Upon Admission (18th Oct 2014) Medications Indications IV Ceftriaxone 2g Serious infection- septicemia and pneumonia. IV Hydrocortisone 100mg Septic shock IV Calcium Chloride 1g Impaired absorption of Ca2+ IV Adrenaline 0.08mg Cardiopulmonary resuscitation
  • 5. Current Medications Medications Indications Date IV Noradrenaline 0.2% 4mg/4ml inj. Acute hypotension 19th Oct 2014 Esomeprazole 40mg inj. Gastro-esophageal reflux 19th until 28th Oct 2014 Acetylcystein 600mg effervescent tab. Paracetamol poisoning 19th until 22nd Oct 2014 Piperacillin 4g + Tazobactam 500mg inj. (Tazocin) Septicemia 19th until 28th Oct 2014 Potassium chloride 10% inj. 10ml Hypokalemia 22nd and 23rd Oct 2014 Magnesium sulphate 50% inj. 5ml Arrhythmias due to hypokalemia 23rd Oct 2014 Human albumin 25% inj. 50ml Hypoalbuminaemia 25th until 28th Oct 2014
  • 6. Cont.. Medications Indications Date Enoxaparin 60mg inj. 0.6ml Prophylaxis of venous thromboembolism 27th and 28th Oct 2014 Metronidazole 500mg/100ml inj. Antibiotic (for anaerobic bacteria) 26th until 28th Oct 2014 Imipenem 500mg, Cilastatin 500mg inj. Antibiotic 28th Oct 2014
  • 7. Indication for TPN 1. Patient have oesophageal perforation 2. Patient was initially unconscious, weak and bed ridden Objective of TPN To provide energy, hydrate patient(resolve KI) and improve nutrition status
  • 8. Calculation of PN Regimen 1.Energy Requirement BMI = 50kg/ (1.8m)2 = 15.43kg/m2 (Underweight) Harris Benedict Formula Women: BEE= 665 + 9.6 x weight (kg) + 1.8 x height(cm) – 4.7 x age(years) = 665+ 9.6 x 50 kg + 1.8 x 180 cm – 4.7 x 86 years = 1064.8 kcal/day
  • 9. Other factors to consider… 1. Confined to Bed - activity factor 1.2 2. Septic Shock - activity factor 1.6 So: 1064.8 kcal x 1.2 x 1.6 = 2044.42kcal2044.42kcal
  • 10. 2. Fluid Requirement = 100 mL/kg for first 10kg body weight + 50 mL/kg for next 10kg body weight + 25mL/kg for each kg >20 = 100 mL/kg x 10kg + 50 mL/kg x 10kg + 25 mL/kg x 30kg = 2250mL2250mL
  • 11. 3. Protein Requirement Adult: 2 g/kg/day x 50 kg = 100 g/day100 g/day 1g nitrogen = 6.25 g protein So, 100g protein contain 16 g nitrogen.
  • 12. Going back to the kcal.. 1 g protein = 4 kcal 100 g protein will contain 400 kcal. NPC = Total calorie – Protein calorie = 2044.42kcal – 400kcal = 1644.42 kcal
  • 13. NPC:N ratio = Total NPC (kcal) / N (g) • =1644.42kcal/ 16 g • = 102 : 1 (Match NPC : N for Stressed Pt) Condition NPC : N Maintenance 150 : 1 Stress 90-120 : 1 Infant 200 : 1 NPC : N Ratio
  • 14. NPC: 43% glucose and 57% lipid Glucose: 1644.42 kcal x 43% == 707 kcal707 kcal Lipid: 1644.42 kcal x 57% = 937.32 kcal= 937.32 kcal
  • 15. 4. Lipid Requirement Calories required = 937.32 kcal Total lipid = 937.32 kcal / 9 kcal/g = 104.14 g 5. Carbohydrate Requirement5. Carbohydrate Requirement Calories required = 707 kcal Total carbohydrate = 707 kcal / 4 kcal/g = 176.75g
  • 16. Calculated Requirement Daily Requirement Volume of The Preparation Content in the Calculated Volume Final Volume Protein 100g 100g contains 16g N 16g/13.5g x1000mL = 1185.19 mL ≈ 1185mL VaminTM14 contains: Na+ = 0.1 x 1185= 118.5mmol K+ = 0.05 x 1185= 59.25mmol Ca+ = 0.005 x 1185= 5.925mmol Mg+= 0.008 x 1185= 9.48mmol Cl- = 0.1x 1185 = 118.5mmol SO42- = 0.008 x 1185 =9.48mmol N=13.5gm/1000mL 1185mL Lipid 104g 20%= 30g / 100mL 104/30 x 100 = 346.67mL≈ 347mL Intralipid 20% 347mL Dextrose 177g 50% = 50g / 100mL 177/50 x 100 = 354mL Dextrose 50% 354 mL
  • 17. Calculated Requirement (Cont.) Daily Requirement Volume of the Preparation Content in the Calculated Volume Final Volume Trace Element (Additrace) 10mL 10mL Phosphate: 50mmol (Use K2HPO4Inj ) 50 x1 =50mL K2HPO4 Inj contains: K+ = 2.0 mmol/ml Phosphate = 1 mmol/l 50 mL Sodium : 100mmol From Vamin: 118mmol 0mL Mg2+ : 10 mmol From Vamin: 9.48mmol 0mL Calcium : 10 mmol (Use CaGlu 10% Inj) From Vamin: 5.925mmol 4mmol / 0.22mmol x 1mL = 18mL CaGlu 10% Inj contains: Ca2+ = 0.22 mmol/ml 18mL
  • 18. Calculated Requirement (Cont.) Daily Requirement Volume of the Preparation Content in the Calculated Volume Final Volume Potassium: 100 mmol From K2HPO4 Inj: 2.0 mmol/mL x 50mL = 100mmol 0mL Water soluble vitamin : (Use Solivito) 10mL Lipid soluble vitamin (Use Vitlipid Adult) 10mL Fluid (Water for Injection) 2250mL – 1984mL = 266mL 266mL TOTAL VOLUME 2250mL
  • 19. TPN REGIMEN PROVIDED Date Regimen Contents 20-10-2014 - 28-10-2014 Kabiven Peripheral Amino Acid 34g Nitrogen 5.4 g Glucose 97g Lipid 51g Total Energy 1000 kcal NPC 900kcal Sodium 32 mmol Chloride 47 mmol Calcium 2 mmol Potassium 24 mmol Magnesium 4 mmol Phosphate 11 mmol Total Volume 1440mL 22-10-2014 & 23-10- 2014 Potassium chloride 10% inj. 10ml 150mg KCl/mL: Potassium 37mmol Chloride 42mmol
  • 20. Overall Comparison and Comments TPN Content TPN Prescribed TPN Calculated Protein 34g 100g Lipid 51g 104g Carbohydrate 97g 177g Total Energy 1900kcal 2044kcal Sodium 32mmol 90mmol Chloride 47mmol 80mmol Calcium 2mmol 10mmol Potassium 24mmol 100mmol Magnesium 4mmol 10mmol Phosphate 11mmol 50mmol Total Fluid Volume 1440mL 2250
  • 21. 1. Renal Profile Increase of urea level --- indication of high protein catabolism. Decreasing level of creatinine towards normal range indicated that AKI is treated properly.
  • 22. 2. Liver Profile Low level of total protein and albumin is an indicator for malnutrition. Low level of protein may be due to high protein catabolism.
  • 23. Elevated levels of ALP and ALT are because of patient’s bile duct disease and usage of TPN.
  • 24. 3. Electrolytes Level Potassium chloride is given to patient on 22nd and 23rd Oct in order to ensure she is not having hypokalemia.
  • 25. 4. Platelet Count Reduced platelets count indicated the septicemia.
  • 26. 5. Culture & Sensitivity Test • 19th Oct 2014 TEST: Blood Culture Anaerobic (Gram Negative) RESULT: + Bacteriodes sp.
  • 27. 6. I/O Chart • + balance shown that patient is having fluid retention since DOA, 19th Oct. This is due to her AKI problem. Edema should be noted.
  • 28. Monitoring Efficacy and Progress • Vital signs  BP, body temperature should be monitored closely as the patient has septic shock. • I/O Chart  To prevent fluid retention or dehydration in patient. • Anthropometry  Patient’s body weight and fluid balance monitored.  Negative fluid balance show success TPN.
  • 29. • Serum/urine glucose level  Patient had a history of DM Type II.  Need to ensure patient can tolerate the glucose content in TPN.  Blood glucose level should be monitored. • Renal + electrolytes status  Indicates appropriate provision or other complicating clinical activity.  AKI. • Proteins  Albumin level is quite low. The patient is malnourished.  Liver enzymes; ALT and ALP are elevated because of liver duct problem and usage of TPN.
  • 30. Monitoring Safety • Metabolic/ Nutritional complication  Monitored level of blood glucose level.  Monitor level of potassium and phosphate to avoid refeeding syndrome. • Technical/Mechanical complication  Check for infection from catheter.  Monitor vital signs.
  • 31. Conclusion The current TPN regimen is not sufficient to fulfill patient’s daily nutrition requirement. However, intervention to increase the doses should be taken only after serious monitoring and consideration on patient’s current kidney and liver functions I/O chart should continue to be monitored closely.
  • 32. References 1. Calvin L. Long, Neal Schaffel, John W. Geiger, William R. Schiller and William S. Blakemore. 1979. Metabolic Response to Injury and Illness: Estimation of Energy and Protein Needs from Indirect Calorimetry and Nitrogen Balance. Journal of Parenteral and Enteral Nutrition 3: 452-456. 2. DR Garrel, N Jobin, LHM De Jonge .1996. Should We Still Use the Harris and Benedict Equations? Nutrition in Clinical Practice Journal 11: 99-103 3. Koneru Veera Raghava Chowdary and Pothula Narasimha Reddy. 2010. Parenteral nutrition: Revisited. Indian Journal of Anaesthesia 54(2): 95-103 4. Gail A. Cresci. 2005. Nutrition Support for the Critically Ill Patient: A Guide to Practice. CRC/Taylor & Francis Group. 5. http://www.cancer.org/healthy/toolsandcalculators/calculators/app/body-mass-calculator 6. Assoc. Prof Fuad Ahmad bin Shamsuddin’s lecture notes on Parenteral Nutrition Support